Evaluation of a nisin-eluting nanofiber scaffold to treat staphylococcus aureus-induced skin infections in mice

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 3928-3935

  Heunis, Tiaan D J ^a   Smith, Carine ^a   Dicks, Leon M T ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ELUTING MOLECULAR SCAFFOLD; MACROGOL; MOLECULAR SCAFFOLD; NISIN; POLYGLACTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BIOLUMINESCENCE; CELL COUNT; CONTROLLED STUDY; ELECTROSPINNING; EPITHELIZATION; GROWTH INHIBITION; KERATINIZATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; TARGET ORGANISM; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BANDAGES; DIFFUSION; DRUG EVALUATION, PRECLINICAL; LUMINESCENT MEASUREMENTS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; NANOFIBERS; NISIN; POLYESTERS; POLYETHYLENE GLYCOLS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; WOUND HEALING; WOUND INFECTION;

EID: 84880280883     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00622-13     Document Type: Article

References (62)

1. Guo S, DiPietro LA. 2010. Factors affecting wound healing. J. Dent. Res. 89:219-229.
2. Gurtner GC, Werner S, Barrandon Y, Longaker MT. 2008. Wound repair and regeneration. Nature 453:314-321.
3. Nishio N, Okawa Y, Sakurai H, Isobe K. 2008. Neutrophil depletion delays wound repair in aged mice. Age 30:11-19.
4. Church D, Elsayed S, Reid O, Winston B, Lindsay R. 2006. Burn wound infections. Clin. Microbiol. Rev. 19:403-434.
5. Vindenes H, Bjerknes R. 1995. Microbial colonization of large wounds. Burns 21:575-579.
6. Baggett HC, Hennessy TW, Leman R, Hamlin C, Bruden D, Reasonover A, Martinez P, Butler JC. 2003. An outbreak of community-onset methicillin- resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect. Control Hosp. Epidemiol. 24:397-402.
7. Daum RS. 2007. Skin and soft-tissue infections caused by methicillinresistant Staphylococcus aureus. N. Engl. J. Med. 357:380-390.
8. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
9. Kim JY. 2009. Understanding the evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Newsl. 31:17-23.
10. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R. 2003. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984.
11. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347.
12. Endimiani A, Blackford M, Dasenbrook EC, Reed MD, Bajaksouszian S, Hujer AM, Rudin SD, Hujer KM, Perreten V, Rice LB, Jacobs MR, Konstan MW, Bonomo RA. 2011. Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio. Antimicrob. Agents Chemother. 55:1684-1692.
13. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RC, Ferraro MJ. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207-208.
14. Walsh C. 1999. Deconstructing vancomycin. Science 284:442-443.
15. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian KD, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJ, Rebuffat S, Ross RP, Sahl HG, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Süssmuth RD, Tagg JR, Tang GL, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA. 2013. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat. Prod. Rep. 30:108-160.
16. Willey JM, van der Donk WA. 2007. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61:477-501.
17. Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, Kaptein R, Bonvin AM, van Nuland NA. 2004. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11:963-967.
18. Brötz H, Josten M, Wiedemann I, Schneider U, Götz F, Bierbaum G, Sahl HG. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
19. Bartoloni A, Mantella A, Goldstein BP, Dei R, Benedetti M, Sbaragli S, Paradisi F. 2004. In-vitro activity of nisin against clinical isolates of Clostridium difficile. J. Chemother. 16:119-121.
20. Piper C, Hill C, Cotter PD, Ross RP. 2011. Bioengineering of a nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants nisin F, Q, and Z. Microb. Biotechnol. 4:375-382.
21. Severina E, Severin A, Tomasz A. 1998. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. J. Antimicrob. Chemother. 41:341-347.
22. Rayman MK, Aris B, Hurst A. 1981. Nisin: a possible alternative or adjunct to nitrite in the preservation of meats. Appl. Environ. Microbiol. 41:375-380.
23. Gut IM, Blanke SR, van der Donk WA. 2011. Mechanisms of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem. Biol. 6:744-752.
24. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. 2002. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J. Biomed. Mater. Res. 60:613-621.
25. Smith LA, Ma PX. 2004. Nano-fibrous scaffolds for tissue engineering. Colloids Surf. B Biointerfaces 39:125-131.
26. Yang F, Murugan R, Wang S, Ramakrishna S. 2005. Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials 26:2603-2610.
27. Zhou Y, Yang D, Chen X, Xu Q, Lu F, Nie J. 2008. Electrospun water-soluble carboxyethyl chitosan/poly(vinyl alcohol) nanofibrous membrane as potential wound dressing for skin regeneration. Biomacromolecules 9:349-354.
28. Agarwal S, Wendorff JH, Greiner A. 2008. Use of electrospinning technique for biomedical applications. Polymer 49:5603-5621.
29. Meinel AJ, Germershaus O, Luhmann T, Merkle HP, Meinel L. 2012. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur. J. Pharm. Biopharm. 81:1-13.
30. Dheraprasart C, Rengpipat S, Supaphol P, Tattiyakul J. 2009. Morphology, release characteristics, and antimicrobial effect of nisin-loaded electrospun gelatin fiber mat. J. Food Prot. 72:2293-2300.
31. Heunis TDJ, Botes M, Dicks LMT. 2010. Encapsulation of Lactobacillus plantarum 423 and its bacteriocin in nanofibers. Probiotics Antimicrob. Proteins 2:46-51.
32. Heunis T, Bshena O, Klumperman B, Dicks L. 2011. Release of bacteriocins from nanofibers prepared with combinations of poly(D,L-lactide) (PDLLA) and poly(ethylene oxide) (PEO). Int. J. Mol. Sci. 12:2158-2173.
33. Torres NI, Sutyak Noll S, Xu S, Li J, Huang Q, Sinko PJ, Wachsman MB, Chikindas ML. 2013. Formulation and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type1 Probiotics Antimicrob. Proteins 5:26-35.
34. Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A. 2004. The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns 30:660-664.
35. Heunis TDJ. 2012. Development of an antimicrobial wound dressing by co-electrospinning bacteriocins of lactic acid bacteria into polymeric nanofibers. PhD thesis. University of Stellenbosch, Stellenbosch, South Africa.
36. Chew SY, Wen J, Yim EKF, Leong KW. 2005. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 6:2017-2024.
37. Kenawy ER, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH, Wnek GE. 2002. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J. Control. Release 81:57-64.
38. Kim K, Luu YK, Chang C, Fang D, Hsiao BS, Chu B, Hadjiargyrou M. 2004. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J. Control. Release 98:47-56.
39. López-Rubio A, Sanchez E, Sanz Y, Lagaron JM. 2009. Encapsulation of living Bifidobacteria in ultrathinPVOHelectrospun fibers. Biomacromolecules 10:2823-2829.
40. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M. 2003. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J. Control. Release 89:341-353.
41. Maretschek S, Greiner A, Kissel T. 2008. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J. Control. Release 127:180-187.
42. Rujitanaroj P, Pimpha N, Supaphol P. 2008. Wound-dressing materials with antibacterial activity from electrospun gelatin fiber mats containing silver nanoparticles. Polymer 49:4723-4732.
43. Kim TG, Lee DS, Park TG. 2007. Controlled protein release from electrospun biodegradable fiber mesh composed of poly(?-caprolactone) and poly(ethylene oxide). Int. J. Pharm. 338:276-283.
44. Zeng J, Xu X, Chen X, Liang Q, Bian X, Yang L, Jing X. 2003. Biodegradable electrospun fibers for drug delivery. J. Control. Release 92:227-231.
45. Hemmila MR, Mattar A, Taddonio MA, Arbabi S, Hamouda T, Ward PA, Wang SC, Baker JR, Jr. 2010. Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery 148:499-509.
46. Martinez LR, Han G, Chacko M, Mihu MR, Jacobson M, Gialanella P, Friedman AJ, Nosanchuk JD, Friedman JM. 2009. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J. Investig. Dermatol. 129:2463-2469.
47. Ostorhazi E, Rozgonyi F, Sztodola A, Harmos F, Kovalszky I, Szabo D, Knappe D, Hoffman R, Cassone M, Wade JD, Bonomo RA, Otvos L, Jr. 2010. Preclinical advantages of intramuscularly administered peptide A3-APOover existing therapies in Acinetobacter baumannii wound infections. J. Antimicrob. Chemother. 65:2416-2422.
48. Ostorhazi E, Holub MC, Rozgonyi F, Harmos F, Cassone M, Wade JD, Otvoss L, Jr. 2011. Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved. Int. J. Antimicrob. Agents 37:480-484.
49. Kumbar SG, Nukavarapu SP, James R, Nair LS, Laurecin CT. 2008. Electrospun poly(lactic acid-co-glycolic acid) scaffolds for skin tissue engineering. Biomaterials 29:1400-1407.
50. Burkatovskaya M, Castano AP, Demidov-Rice TN, Tegos GP, Hamblin MR. 2008. Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice. Wound Repair Regen. 16:425-431.
51. Kiyozumi T, Kanatani Y, Ishihara M, Saitoh D, Shimizu J, Yura H, Suzuki S, Okada Y, Kikuchi M. 2007. The effect of chitosan hydrogel containing DMEM/F12 medium on full-thickness skin defects after deep dermal burn. Burns 33:642-648.
52. Sundaramurthi D, Vasanthan KS, Kuppan P, Krishnan UM, Sethura-man S. 2012. Electrospun nanostructured chitosan-poly(vinyl alcohol) scaffolds: a biomimetic extracellular matrix as dermal substitute. Biomed. Mater. 7:1-12.
53. Uppal R, Ramaswamy GN, Arnold C, Goodband R, Wang Y. 2011. Hyaluronic acid nanofiber wound dressing-production, characterization, and in vivo behaviour. J. Biomed. Mater. Res. B Appl. Biomater. 97B:20-29
54. Merrell JG, McLaughlin SW, Tie L, Laurecin CT, Chen AF, Nair LS. 2009. Curcumin-loaded poly(?-caprolactone) nanofibres: diabetic wound dressing with antioxidant and anti-inflammatory properties. Clin. Exp. Pharmacol. Physiol. 36:1149-1156.
55. Liu X, Lin T, Fang J, Yao G, Zhao H, Dodson M, Wang X. 2010. In vivo wound healing and antibacterial performances of electrospun nanofibre membranes. J. Biomed. Mater. Res. A 94A:499-508.
56. Rho KS, Jeong L, Lee G, Seo BM, Park YJ, Hong SD, Roh S, Cho JJ, Park WH, Min BM. 2006. Electrospinning of collagen nanofibers: effects on the behaviour of normal human keratinocytes and early-stage wound healing. Biomaterials 27:1452-1461.
57. Choi JS, Leong KW, Yoo HS. 2008. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 29:587-596.
58. Liu X, Lin T, Gao Y, Xu Z, Huang C, Yao G, Jiang L, Tang Y, Wang X. 2012. Antimicrobial electrospun nanofibers of cellulose acetate and polyester urethane composite for wound dressing. J. Biomed. Mater. Res. B Appl. Biomater. 100B:1556-1565.
59. Barak O, Treat JR, James WD. 2005. Antimicrobial peptides: effectors of innate immunity in the skin. Adv. Dermatol. 21:357-374.
60. Pinto D, Marzani B, Minervini F, Calasso M, Giuliani G, Gobbetti M, De Angelis M. 2011. Plantaricin A synthesized by Lactobacillus plantarum induces in vitro proliferation and migration of human keratinocytes and increases the expression of TGF-1, FGF7, VEGF-A and IL-8 genes. Peptides 32:1815-1824.
61. Marzani B, Pinto D, Minervini F, Calasso M, Di Cagno R, Giuliani G, Gobbetti M, De Angelis M. 2012. The antimicrobial peptide pheromone plantaricin A increases antioxidant defenses of human keratinocytes and modulates the expression of filaggrin,-defensin 2 and tumor necrosis factor-genes. Exp. Dermatol. 21:665-671.
62. Kindrachuk J, Jenssen H, Elliott M, Nijnik A, Magrangeas-Janot L, Pasupuleti M, Thorson L, Ma S, Easton DM, Bains M, Finlay B, Breukink EJ, Sahl HG, Hancock REW. 2013. Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory. Innate Immun. 19:315-327.